Table 4.
Characteristics | Risk ratio (95% CI) | P-value |
---|---|---|
Closing index | 1.002 (0.65, 1.54) | 0.994 |
Age (10-year units) | 0.92 (0.85, 1.01) | 0.067 |
Male (vs female) | 0.76 (0.61, 0.95) | 0.015 |
Black (vs white) | 1.41 (1.13, 1.77) | 0.002 |
Hispanic (vs white) | 0.82 (0.58, 1.17) | 0.277 |
Other race (vs white) | 1.5 (0.92, 2.44) | 0.101 |
Obese (vs not) | 0.97 (0.77, 1.21) | 0.792 |
Study, ref. = STAN | ||
CPAP | 0.67 (0.47, 0.94) | 0.021 |
MeCIS | 0.55 (0.31, 0.99) | 0.046 |
SARA | 1.16 (0.86, 1.56) | 0.347 |
SARCA | 1.26 (0.94, 1.7) | 0.119 |
CPAP, Effect of Positive Airway Pressure on Reducing Airway Reactivity in Patients with Asthma; EPAC, episode of poor asthma control; MeCIS, Methacholine Bronchoprovocation – Influence of High-Potency Inhaled Corticosteroids in Asthma; SARA, Study of Acid Reflux and Asthma; SARCA, Study of Acid Reflux in Childhood Asthma; STAN, Study of Asthma and Nasal Steroids.